MARBLE DUST
Colorectal Cancer
James VaraniSmall moleculePhase 2/3Dormant
BB
71/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 59/ 100
- Competitive Position
- 95/ 100
Competitive context
714 Active assets in the Colorectal Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Desflurane Peter MacCallum Cancer Centre, Australia | Phase 4 | BBB |
Orectalip Sinphar Pharmaceutical Co., Ltd | Phase 4 | BB |
FLUOROURACILUM UNICANCER | Phase 4 | BB |
Levofolinic Acid Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Phase 3 | BB |
FENTANYL Mansoura University | Phase 4 | BB |
View all 50 →
Same molecule, other indications
MARBLE DUST is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →